APEN
Apollo Endosurgery, Inc.
Set alert
52-week range unavailable
- Open
- 9.93
- Prev close
- 10.00
- Mkt cap
- 579.72M
- Vol
- 1.64M
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 9.92
- High
- 10.00
- Forward P/E
- -11.36
- Beta
- 2.32
- Short ratio
- 0.35
- Inst. own
- 63.41%
- Dividend
- 0.00
- Ex-div date
- Earnings
- May 2, 2023
- 50-d avg
- 9.94
- 200-d avg
- 7.73
- 1y target
- 10.00
Key statistics
- Market cap
- 579.72M
- Enterprise value
- 579.78M
- Trailing P/E
- 0.00
- Forward P/E
- -11.36
- PEG ratio
- 0.00
- Price / sales
- 7.54
- Price / book
- 12.89
- EPS (TTM)
- -1.06
- Beta
- 2.32
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -51.84%
- Revenue (TTM)
- 76.86M
- Revenue growth
- 31.80%
- Free cash flow
- -19.84M
- Total cash
- 57.00M
- Total debt
- 57.06M
- Return on equity
- -84.92%
- Shares outstanding
- 47.55M
- Short % of float
- 1.14%
- 50-day average
- 9.94
- 200-day average
- 7.73
Analyst view
Consensus: buy
- Strong buy0
- Buy2
- Hold0
- Sell0
- Strong sell0
Next earnings
May 2, 2023
Expected May 2, 2023. Consensus EPS estimate -0.21.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| May 2, 2023 | Mar 1, 2023 | 0.00 | — | — | — |
| Apr 4, 2023 | Dec 1, 2022 | -0.21 | — | — | — |
| Nov 1, 2022 | Sep 1, 2022 | -0.21 | — | — | — |
| Aug 2, 2022 | Jun 1, 2022 | -0.21 | — | — | — |
| May 3, 2022 | Mar 1, 2022 | -0.21 | — | — | — |
| Feb 22, 2022 | Dec 1, 2021 | -0.20 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jan 23, 2023 | Cowen & Co. | down | Outperform | Market Perform |
| Jan 4, 2023 | Stifel | down | Buy | Hold |
| Nov 30, 2022 | Lake Street | down | Buy | Hold |
| May 4, 2022 | Stephens & Co. | main | — | Overweight |
| Feb 23, 2022 | Stifel | main | — | Buy |
| Dec 15, 2021 | Cowen & Co. | init | — | Outperform |
About Apollo Endosurgery, Inc.
Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices for gastrointestinal therapeutic endoscopy. The company offers OverStitch and OverStitch Sx Endoscopic Suturing Systems that enable advanced endoscopic procedures by allowing physicians to suture and secure the approximation of tissue through a flexible endoscope. It also provides Orbera, an intragastric balloon system that reduces stomach capacity causing patients to consume less following the procedure, and delays gastric content emptying, which assists the patient in losing weight under the Orbera Intragastric Balloon System, BIB, and Orbera365 Managed Weight Loss System brands. In addition, the company offers X-Tack Endoscopic HeliX Tacking System, a suture-based device for closing and healing defects in the lower and upper gastrointestinal tract. The company sells its products to medical service providers, hospitals, outpatient surgical centers, clinics, and physicians in the United States, Costa Rica, Australia, and other European countries. Apollo Endosurgery, Inc. was founded in 2005 and is headquartered in Austin, Texas.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- apolloendo.com
News
- Weight Loss Services Market Analysis Report 2024-2030, Featuring Profiles of Atkins Nutritionals, Precor, Apollo Endosurgery, Johnson Health Tech, Life Fitness, iFIT, Torque Fitness and More
- Benzinga's Top Ratings Upgrades, Downgrades For November 30, 2022
- APOLLO ENDOSURGERY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Apollo Endosurgery, Inc. - APEN
- SHAREHOLDER ALERT: Weiss Law Investigates Apollo Endosurgery, Inc.
- Buy-rated Boston Scientific's $615 million takeover of Apollo Endosurgery is a positive, says Needham
- Apollo Endosurgery Stock Soars on Buyout Buzz
- Boston Scientific to acquire Apollo Endosurgery for $615 million in cash
- Apollo Endosurgery to be Acquired by Boston Scientific
- Boston Scientific Announces Agreement to Acquire Apollo Endosurgery, Inc.
- Apollo Endosurgery, Inc. (APEN) Q3 2022 Earnings Call Transcript
Your note
Sign in to keep a note on APEN — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ANDERSON RICK D | Director and Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) | Jun 13, 2022 | 113,484 |
| BARR JOHN R | Director | Stock Award(Grant) | Jun 13, 2022 | 44,082 |
| BLACK JEFFREY G | Chief Financial Officer | Stock Award(Grant) | Jun 13, 2022 | 353,900 |
| CPMG, INC. | Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | Dec 27, 2022 | 0 |
| MCCLELLAN WILLIAM D JR | Director | Stock Award(Grant) | Jun 13, 2022 | 39,249 |
| MCGAUGHY R KENT JR | Director and Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | Dec 27, 2022 | 0 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| CPMG INC | 10.67% | 6,183,603 | 61.84M | Dec 30, 2022 |
| Nantahala Capital Management, LLC | 7.00% | 4,056,627 | 40.57M | Dec 30, 2022 |
| Stonepine Capital Management, LLC | 6.43% | 3,726,584 | 37.27M | Dec 30, 2022 |
| Citigroup Inc. | 4.12% | 2,386,557 | 23.87M | Dec 30, 2022 |
| Deerfield Management Company, L.P. (Series C) | 3.02% | 1,750,000 | 17.50M | Dec 30, 2022 |
| Gagnon Securities, LLC | 2.94% | 1,703,175 | 17.03M | Dec 30, 2022 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 1.84% | 876,959 | 8.77M | Sep 29, 2022 |
| Vanguard Extended Market Index Fund | 0.92% | 436,912 | 4.37M | Sep 29, 2022 |
| Arbitrage Fund | 0.76% | 359,000 | 3.59M | Nov 29, 2022 |
| Fidelity Extended Market Index Fund | 0.39% | 184,992 | 1.85M | Nov 29, 2022 |
| Federated Hermes Kaufmann Fund | 0.28% | 133,281 | 1.33M | Oct 30, 2022 |
| Bridgeway Funds Inc-Ultra Small Company Fund | 0.19% | 90,800 | 908.00K | Sep 29, 2022 |